indose Archives - Green Market Report

William SumnerWilliam SumnerMay 3, 2019
daily_hit004-1280x533.png

5min8130

It’s time for your Daily Hit of cannabis financial news for May 3, 2019.

On The Site

Indose

Indose, a groundbreaking precise dosage vaporizer that measures and displays exact dosage in real-time, down to the milligram, for a customized and controlled cannabis experience, announced today that it has closed a $3.5 million Series A round led by Casa Verde Capital.

Millennials Are Beginning Cannabis Careers Through Summer Internships

An increasing number of North American cannabis companies are reaching out to college students, offering summer internships as an opportunity to get their foot in the door in the growing industry. Students now are being given opportunities that students only 5 years ago could have only dreamed of!

Green Market Report’s Marijuana Money May 3, 2019

Green Market Report just learned that one of the sponsors at next week’s Green Market Summit is going to be announcing a new product at the conference. This is going to be huge news. We still have some room left, but there is a limited about of seats. Get your tickets before it’s too late.

In Other News

TerrAscend

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has announced that its manufacturing facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice certificate in according with European Union (EU) laws; which will allow the company to export medical cannabis to the EU. The company also announced that it has entered into a comprehensive sales and distribution agreement with the German pharmaceutical wholesaler, iuvo Therapeutics GmbH. “Just five months ago, TerrAscend became the first North American Operator (NAO), with scale operations in both Canada and the US. Upon commencement of shipments this quarter, through our partner iuvo in Germany, TerrAscend will be the first and only global cannabis operator with sales in the three largest markets in the world,” said Dr. Michael Nashat, CEO of TerrAscend.

iAnthus

iAnthus Capital Holdings Inc. (CSE: IAN) (OTCQX: ITHUF) announced that it has completed a private placement offering of an incremental $25 million of unsecured convertible notes and corresponding warrants, as an add-on to a previously announced private placement of $35 million. The notes will mature on March 15, 2023 and will carry an annual interest of 8%.

Fire & Flower

Fire & Flower Holdings Corp. (TSXV: FAF) announced that it has entered into a definitive agreement to acquire four licensed cannabis dispensaries from Prairie Sky Cannabis Inc. for $13 million, half of which will be paid in cash and the other half in common shares of the company. The dispensaries, which are under the brand name Jimmy’s Cannabis Shop, are located in the Saskatchewan communities of Battleford, Estevan, Martensville, and Moosomin. “The acquisition of four additional retail cannabis stores in the province of Saskatchewan is the first in Fire & Flower’s aggressive acquisition strategy for 2019,” said Fire & Flower CEO Trevor Fencott. “In conjunction with our Open Fields wholesale distribution platform in the province, it cements our leadership position in this strategic market.”


StaffStaffMay 3, 2019
Indose-Packaging-Image_Press-Kit-1024x683-1.jpg

4min19900

Indose, a groundbreaking precise dosage vaporizer that measures and displays exact dosage in real-time, down to the milligram, for a customized and controlled cannabis experience, announced today that it has closed a $3.5 million Series A round led by Casa Verde Capital.

Vaporizers are currently the fastest growing segment in cannabis, according to market research company ArcView. By next year, the vape segment of the legal marijuana industry in the United States is expected to more than triple to $3.9 billion. By 2021, vape sales are predicted to surge to a total of $5.2 billion — accounting for 25% of the entire industry.

Indose brings to market a proprietary metered vape pen technology that measures the precise dose — down to the milligram — of THC delivered with every draw. As a person inhales, their dosage is shown in real-time on an LED display that ranges from .05 MG to 4 MG, creating an individualized, controlled cannabis vaping experience.

The device is a drastic improvement over existing vaporizers on the market that provide either no control over dosage, or a one-size-fits-all approach using timers to deliver the same dose to everyone.

This $3.5 million raise will go towards expanding partnerships with cannabis oil manufacturers and brands across the country, increasing the size of the R&D team, filing for additional patents, and pursuing medical device certification.

“Dosage control is key to an effective and consistent cannabis experience, and there is no such thing as a universal dosage that is right for everyone,” said Indose co-founder and CEO Benzi Ronen.

Following three years of intensive research and development (and 15 filed patents) the Indose vaporizer features two proprietary sensors which take 10 measurements per second to calculate the precise milligrams of THC and CBD being inhaled by the user. This dosage is presented on the device in real time via an easy to read LED display. Whereas less sophisticated dosage-driven vapes deliver a “standard dose” between 2 and 3 MG, Indose allows users to micro-dose in .05 MG increments.

“We created Indose to address the critical gap we observed with first-generation vaporizers that guestimate dosage based on draw time or by moderating the temperature of the heating element. There is no universal dosage amount that is consistent to everyone regardless of their stature, experience or tolerance level. Dosage needs to be modified to each individual based on their receptors, body attributes and desired effects. With people using cannabis for therapeutic reasons in mind, we’ve developed a science-backed delivery system that’s both precise and personalized.”

Indose is democratizing this medical-grade device at an affordable price point. The vaporizer retails for less than $70, is recyclable, and comes paired with some of the world’s top cannabis oil brands — further customizing the experience. Indose is currently available in select pilot dispensaries in California and will announce a large-scale distribution partnership this summer.

“With decades of combined experience in product development and manufacturing, the Indose team was uniquely positioned to develop this innovative new technology,” said Karan Wadhera, Managing Partner of Casa Verde Capital. “We believe precise, self-regulated and responsible dosage will be the next frontier in vape delivery systems, and Indose is ahead of the curve with a device that brings medical precision to the mainstream.”

 


AxisWireAxisWireMay 3, 2019
Indose-Packaging-Image_Press-Kit-1024x683.jpg

5min9540

CASA VERDE INVESTS IN WORLD’S FIRST METERED DOSAGE VAPORIZER TECHNOLOGY

The Indose vaporizer measures and displays exact dosage in real-time, down to the milligram, for a customized and controlled cannabis experience.

NEW YORK, NY., May 3rd, 2019 /AxisWire/ – Indose, a groundbreaking precise dosage vaporizer, today announced it has closed a $3.5 million Series A round led by Casa Verde Capital. The California-based venture capital firm, which focuses exclusively on the cannabis industry, boasts a diverse portfolio of leading businesses such as Metrc, Dutchie, Vangst, Green Bits, LeafLink and more.

Indose brings to market a proprietary metered vape pen technology that measures the precise dose — down to the milligram — of THC delivered with every draw. As a person inhales, their dosage is shown in real-time on an LED display that ranges from .05 MG to 4 MG, creating an individualized, controlled cannabis vaping experience. The device is a drastic improvement over existing vaporizers on the market that provide either no control over dosage, or a one-size-fits-all approach using timers to deliver the same dose to everyone.

“Dosage control is key to an effective and consistent cannabis experience, and there is no such thing as a universal dosage that is right for everyone,” said Indose co-founder and CEO Benzi Ronen. “We created Indose to address the critical gap we observed with first-generation vaporizers that guestimate dosage based on draw time or by moderating the temperature of the heating element. There is no universal dosage amount that is consistent to everyone regardless of their stature, experience or tolerance level. Dosage needs to be modified to each individual based on their receptors, body attributes and desired effects. With people using cannabis for therapeutic reasons in mind, we’ve developed a science-backed delivery system that’s both precise and personalized.”

Following three years of intensive research and development (and 15 filed patents) the Indose vaporizer features two proprietary sensors which take 10 measurements per second to calculate the precise milligrams of THC and CBD being inhaled by the user. This dosage is presented on the device in real time via an easy to read LED display. Whereas less sophisticated dosage-driven vapes deliver a “standard dose” between 2 and 3 MG, Indose allows users to micro-dose in .05 MG increments.

Indose is democratizing this medical-grade device at an affordable price point. The vaporizer retails for less than $70, is recyclable, and comes paired with some of the world’s top cannabis oil brands — further customizing the experience. Indose is currently available in select pilot dispensaries in California and will announce a large-scale distribution partnership this summer.

“With decades of combined experience in product development and manufacturing, the Indose team was uniquely positioned to develop this innovative new technology,” said Karan Wadhera, Managing Partner of Casa Verde Capital. “We believe precise, self-regulated and responsible dosage will be the next frontier in vape delivery systems, and Indose is ahead of the curve with a device that brings medical precision to the mainstream.”

Vaporizers are currently the fastest growing segment in cannabis, according to market research company ArcView. By next year, the vape segment of the legal marijuana industry in the United States is expected to more than triple to $3.9 billion. By 2021, vape sales are predicted to surge to a total of $5.2 billion — accounting for 25% of the entire industry.

This $3.5 million raise will go towards expanding partnerships with cannabis oil manufacturers and brands across the country, increasing the size of the R&D team, filing for additional patents, and pursuing medical device certification.

For more information, please visit www.indose.com

About Indose

Indose is the world’s first real-time, metered precise dosage vaporizer, co-founded by tech entrepreneur and Farmigo CEO Benzi Ronen and brothers Ari and Dani Freeman. Together, they have launched dozens of products to thousands of retailers worldwide, raising over $100 MM in financing.

About Casa Verde

Casa Verde Capital (“CVC”) is the leading venture capital firm focusing exclusively on the cannabis industry. As both the domestic and international cannabis markets continue to evolve and mature, CVC maintains a view that the cannabis industry will be among the most compelling investment themes of our generation.

Press Contacts:

Trailblaze PR
Lisa Weser | lisa@trailblazepr.com
Jenny Gorenstein | jenny@trailblazepr.com



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 17 hours

“Your path you must decide” – Yoda How to Choose the Best

@GreenMarketRpt – 18 hours

Happy Friday! Green Market Report’s Marijuana Money October 23, 2020

@GreenMarketRpt – 2 days

RT : “Industry leaders are hoping that 2021 will be the turnaround after a monumentally tragic year where the lingering effects o…

Back to Top

You have Successfully Subscribed!